NYLIM
AVNS

New York Life Investment Management’s Avanos Medical AVNS Stock Holding History

New York Life Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,202
Closed -$362K – 903
2024
Q1 		$362K Buy
18,202
+6,500
+56% +$126K ﹤0.01% 1156
2023
Q4 		$262K Sell
11,702
-270
-2% -$5.57K ﹤0.01% 1259
2023
Q3 		$242K Sell
11,972
-1,899
-14% -$43K ﹤0.01% 1244
2023
Q2 		$355K Sell
13,871
-2,822
-17% -$74.3K ﹤0.01% 1158
2023
Q1 		$496K Sell
16,693
-238
-1% -$6.91K 0.01% 693
2022
Q4 		$458K Buy
16,931
+1,907
+13% +$46.6K 0.01% 981
2022
Q3 		$327K Buy
15,024
+1,103
+8% +$28.8K ﹤0.01% 1064
2022
Q2 		$381K Buy
+13,921
New +$400K ﹤0.01% 1022
2015
Q4 		– Sell
-9,080
Closed -$258K – 66
2015
Q3 		$258K Buy
9,080
+438
+5% +$15.3K 0.02% 185
2015
Q2 		$350K Buy
+8,642
New +$388K 0.04% 138

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

New York Life Investment Management's AVNS Position: Q2 2024 in Review

New York Life Investment Management sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 18,202 shares — an estimated $362K sold.

New York Life Investment Management first reported a position in AVNS in Q2 2015 and held it in 10 quarters. The position peaked at $496K in Q1 2023. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • New York Life Investment Management reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 18,202 Avanos Medical shares in Q2 2024, an estimated $362K.
  • New York Life Investment Management first reported a position in Avanos Medical in Q2 2015 and held it in 10 quarters.
  • New York Life Investment Management's Avanos Medical position peaked at $496K in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.